Post graduate CME in hematology 2025 pgcmehematology.net August 19th to 21st 2025 Registeration is open - Department of Hematology and Department of Transfusion Medicine & Immunohematology Christian Medical College, Vellore

For readers interested in novel approaches to target Gram-negative bacteria, as exemplified by Roche's macrocyclic peptide antibiotic zosurabalpin, here's a review nature.com/articles/s4157… rdcu.be/enYnj

केजीएमयू कुलपति डॉक्टर सोनिया नित्यानंद को दिल्ली में राष्ट्रपति के हाथों मिला पद्मश्री सम्मान।

Lancet Hematology June edition out!! Focused on toxicity!! Much needed Over the past decades, treatments for blood cancers have expanded, but many don’t improve survival or quality of life. 🩸 The Lancet Haematology tomasz baniak & CSO highlight the need for better toxicity reporting,

sganguly Inhibition of xanthine oxidase by allopurinol--> Increase 6MP accumulation --> Cytopenia XO converts 6MP to 6-TUA, thereby decreasing AZAs cytopenic effects. Worse if TPMT or NUD15 mutated individuals.

#Blockurdate 12/6/25, 7-8 pm ECHO online CME CML - From root to remedies Dr Manas Kalra Satya Prakash Yadav Shruti Kakkar Vinay Munikoty Venkatesh Gargi Das Deepak Bansal Shweta Bansal Dr Neha Rastogi Pritam Singha Roy MD, DM Bharat Agarwal Badira Cheriyalinkal Parambil

#BLOCKURDATE 10th Midterm PHO CME 2025 PGICH #Noida Learn more about #PedALL & #thalassemia #Registrations open Dr Manas Kalra Nita Radhakrishnan Shruti Kakkar Satya Prakash Yadav Silky Jain Shweta Bansal Dr Neha Rastogi Anand KC Pritam Singha Roy MD, DM Dr Gaurav Kharya

Conclusions from Bv-CHEP for Adult T Cell Lymphoma/Leukemia 1. High ORR & CR 2. Good Long-term survival w AlloSCT in CR1 3. It is possible to do ATLL-specific trials in the US. We can do better. Let's keep trying. onlinelibrary.wiley.com/doi/10.1111/bj… HTLV Aware #HTLV #ATLL Boston Medical Center

Low-Dose Anti-PD1 Immune Checkpoint Inhibitors in Relapsed/Refractory Hodgkin #Lymphoma: A Systematic Review. Read the full article. brnw.ch/21wTgyK #ChildhoodCancer

Main take aways from recent trials on MRD directed therapy for newly diagnosed myeloma presented by Aurore Perrot #IMWG25 International Myeloma Foundation

Ugur Journal of Clinical Oncology Myeloma Society International Myeloma Foundation Nikhil C. Munshi, MD marivi mateos Sagar Lonial MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Noopur Raje Chng Wee Joo nizar jacques bahlis Irene Ghobrial Shaji Kumar That’s not possible. 4;14 and 14;16 are mutually exclusive. If you see it in same patient either it’s two separate clones or lab error and either case NOT high risk

🧬✨ ATRA Goes Beyond APL! 🔬💊 All-trans retinoic acid (ATRA), the vitamin A derivative that cured APL by reactivating differentiation in leukemic blasts, is now stepping into non-APL AML 🧠🔥 🧱 In a new twist, ATRA doesn’t target blasts directly—but instead acts on the bone

Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management onlinelibrary.wiley.com/doi/10.1002/aj… #lymsm

📣 The second edition of the EU CAR-T Handbook is here to advance clinical practice and education 📣 💡 Jointly developed by EBMT, European Hematology Association, and the GoCART_Coalition, it is a comprehensive, open-access resource covering the latest developments in the field of CAR-T — a

Remarkable work by Yash Pershad and team on CHIP dynamics over 16 years in ~7,000 women out now in Blood Journals Portfolio! Longitudinal CHIP studies remain rare - this depth of follow-up is invaluable. Correlates and Consequences of Clonal Hematopoiesis Expansion Rate: A 16-Year

2025 focused update of the 2020 ISTH #guidelines for management of #thrombotic thrombocytopenic purpura jthjournal.org/article/S1538-…

Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine nejm.org/doi/full/10.10…

If #cardiotoxicity occurs during #chemotherapy, should we stop the treatment?🫀 Presented by Dr Darryl Leong: ⚖️ Permissive cardiotoxicity balances effective #cancer therapy with #CVrisk management by: 📍Careful cardiac monitoring 📍Cardioprotective medications ➡️ ⚠️Limited

In the new episode of The Hematologist Podcast, Dr. Surbhi Shah sits down with Dr. Keith McCrae to discuss pathways to treatment of Hereditary Hemorrhagic Telangiectasia. Don’t miss out! Listen now: ow.ly/PSIA50Wgk5T #Hematology

RAS Mutation Identifies a Poor Prognostic Molecular Subtype of Therapy-Related Myeloid Neoplasm - PubMed ⁦Mayo Clinic Comprehensive Cancer Center⁩ #RAS pubmed.ncbi.nlm.nih.gov/40402688/